Evidence map›Paper›PMID 36234977›Full record

ReviewMolecules (Basel, Switzerland)2022

Magnolol as a Potential Anticancer Agent: A Proposed Mechanistic Insight.

Xiaofeng Wang, Qingqing Liu, Yuanfeng Fu, Ren-Bo Ding, Xingzhu Qi, Xuejun Zhou, Zhihua Sun, Jiaolin Bao

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Baohe Pingwei power plus neoadjuvant chemotherapy for gastric cancer.World journal of gastrointestinal surgery · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Magnolol Inhibits the Growth ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Xiaofeng WangDepartment of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China.
Qingqing LiuKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Collaborative Innovation Center of One Health, Hainan University, Haikou 570228, China.
Yuanfeng FuKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Collaborative Innovation Center of One Health, Hainan University, Haikou 570228, China.
Ren-Bo DingKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Collaborative Innovation Center of One Health, Hainan University, Haikou 570228, China.
Xingzhu QiKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Collaborative Innovation Center of One Health, Hainan University, Haikou 570228, China.
Xuejun ZhouDepartment of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Hainan Medical University, Haikou 570102, China.
Zhihua SunState International Joint Research Center for Animal Health Breeding, Key Laboratory of Control and Prevention of Animal Disease of Xinjiang Production & Construction Corps, College of Animal Science and Technology, Shihezi University, Shihezi 832003, China.ORCID 0000-0002-2670-3578
Jiaolin BaoKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Collaborative Innovation Center of One Health, Hainan University, Haikou 570228, China.ORCID 0000-0003-0630-071X
Hainan University · CNHainan Medical University · CNUniversity of Macau · MOShihezi University · CN

Funding

Hainan Provincial Natural Science Foundation of China 820QN248Hainan Provincial Natural Science Foundation of China 822QN300Hainan Provincial Natural Science Foundation of China 822RC649the National Natural Science Foundation of China 82104057the National Natural Science Foundation of China 82203206the Open Research Project Program of the State Key Laboratory of Quality Research in Chinese Medicine (University of Macau) SKL-QRCM-OP20009the Scientific Research Foundation of Hainan University KYQD(ZR)-21030the Scientific Research Foundation of Hainan University KYQD(ZR)-21169
6 · The paper itself

Abstract

Cancer is a serious disease with high mortality and morbidity worldwide. Natural products have served as a major source for developing new anticancer drugs during recent decades. Magnolol, a representative natural phenolic lignan isolated from

Indexed as

Antineoplastic AgentsBiological ProductsLignansApoptosisBiphenyl CompoundsNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesAntineoplastic AgentsBiological ProductsBiphenyl CompoundsLignansmagnololNF-kappa BPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTOR Serine-Threonine Kinasesanticancermagnololmolecular mechanismnatural productssignaling pathway

Identifiers

PMID36234977
PMCPMC9570903
OpenAlexW4297988289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.